Marker Therapeutics, Inc. Share Price
NASDAQ: MRKR | Micro CapMarker Therapeutics, Inc. Stock Performance
Open $1.15 | Prev. Close $1.12 | Circuit Range N/A |
Day Range $1.15 - $1.15 | Year Range $0.83 - $2.44 | Volume 1,089 |
Average Traded $1.15 |
Marker Therapeutics, Inc. Share Price Today
As of 11 August 2026, Marker Therapeutics, Inc.'s share price is $1.15. The stock opened at $1.15, compared to its previous close of $1.12. During today's trading session, Marker Therapeutics, Inc.'s share price traded between $1.15 and $1.15, with an average price of $1.15. Over the past 52 weeks, the stock has recorded a high of $2.44 and a low of $0.83. In terms of performance, Marker Therapeutics, Inc.'s share price has declined by 22.64% over the last six months and is up 24.46% on a year-on-year basis.
Marker Therapeutics, Inc. Share Price Chart
Marker Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $17.53M | PE Ratio (TTM) -1.45 | Dividend Yield N/A |
EPS (TTM) $-0.79 | Revenue (TTM) $3.55M | Return On Equity (TTM) -72.42% |
Profit Margin -342.96% | Debt to Equity 0.14 | Quarterly Earnings Growth YoY 13.41% |
Marker Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Marker Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Marker Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.27 | $1.15 | +3.15% |
Jul 2026 | $1.47 | $1.11 | -25.50% |
Jun 2026 | $1.48 | $1.49 | -4.79% |
May 2026 | $1.46 | $1.56 | +10.60% |
Apr 2026 | $1.33 | $1.42 | +8.85% |
Mar 2026 | $1.46 | $1.30 | -12.16% |
Feb 2026 | $1.62 | $1.48 | -8.07% |
Jan 2026 | $1.53 | $1.61 | +10.27% |
Dec 2025 | $1.24 | $1.46 | +18.22% |
Nov 2025 | $0.96 | $1.24 | +22.28% |
Oct 2025 | $0.89 | $1.01 | +14.00% |
Sep 2025 | $0.89 | $0.89 | -3.70% |
MRKR Share Price FAQs
What is Marker Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Marker Therapeutics, Inc. stock?
What is MRKR's market capitalisation today?
What is MRKR's net income for the last quarter?
What is the 5 year returns of MRKR?
What is the high & low stock price of MRKR today?
Can I buy MRKR shares in India?